The aim of the study was to quantify the burden of hospitalization for papillomavirus (HPV)-related diseases in Tuscany between 2002 and 2014 through a retrospective analysis of routinely collected hospital data.In total, the HPV-related hospitalizations were 15,021. The average annual hospitalization rate (HR) was 31.6 (43.8 for females; 18.6 for males) per 100,000. From the beginning to the end of the study period, the HR for genital warts decreased by 19.9% among females, whereas it remained stable among males. While the HR for cervical cancers decreased by 35.3%, the HR for oropharyngeal cancer remained stable in both genders, and the HR for anal cancer increased by 56.7% among females and by 14.5% among males. Overall, a declining trend in the HR for HPV-attributable diseases was observed (from 33.4 to 28.0/100,000), and can be ascribed to the cervical cancer screening programme. The burden of the HPV-related diseases other than cervical cancer and genital warts in females remained stable or increased. In this context, the recommendation to extend the HPV vaccination programme to include boys in their 12th year of life, contained in the recently approved National Vaccine Plan 2016-2018, is particularly welcome.
The burden of hospitalization due to HPV infections in Tuscany, Central Italy / Levi, M.; Bellini, I.; Sinisgalli, E.; Sala, A.; Indiani, L.; Bonanni, P.. - In: PUBLIC HEALTH. - ISSN 0033-3506. - ELETTRONICO. - 141:(2016), pp. 194-197. [10.1016/j.puhe.2016.09.031]
The burden of hospitalization due to HPV infections in Tuscany, Central Italy
LEVI, MIRIAM;BELLINI, IRENE;SINISGALLI, ERSILIA;SALA, ANTONINO;INDIANI, LAURA;BONANNI, PAOLO
2016
Abstract
The aim of the study was to quantify the burden of hospitalization for papillomavirus (HPV)-related diseases in Tuscany between 2002 and 2014 through a retrospective analysis of routinely collected hospital data.In total, the HPV-related hospitalizations were 15,021. The average annual hospitalization rate (HR) was 31.6 (43.8 for females; 18.6 for males) per 100,000. From the beginning to the end of the study period, the HR for genital warts decreased by 19.9% among females, whereas it remained stable among males. While the HR for cervical cancers decreased by 35.3%, the HR for oropharyngeal cancer remained stable in both genders, and the HR for anal cancer increased by 56.7% among females and by 14.5% among males. Overall, a declining trend in the HR for HPV-attributable diseases was observed (from 33.4 to 28.0/100,000), and can be ascribed to the cervical cancer screening programme. The burden of the HPV-related diseases other than cervical cancer and genital warts in females remained stable or increased. In this context, the recommendation to extend the HPV vaccination programme to include boys in their 12th year of life, contained in the recently approved National Vaccine Plan 2016-2018, is particularly welcome.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
